FDA Patient Engagement Advisory Committee meeting – November 15th

When:
November 15, 2018 all-day
2018-11-15T00:00:00-08:00
2018-11-16T00:00:00-08:00

FDA Patient Engagement Advisory Committee meeting – November 15th

Patient Affairs Staff (PAS)

Food and Drug Administration

U.S. Department of Health and Human Services

Reminder: FDA Patient Engagement Advisory Committee meeting – November 15th

On November 15, 2018, the FDA’s Patient Engagement Advisory Committee (PEAC) will hold its second public meeting to discuss how the FDA can use patient-driven platforms, such as those that utilize social media, digital health technology, and patient registry data, to inform the regulatory evaluation of medical devices. The number of people turning to the Internet to find and share health information continues to grow.  Social media channels aid the creation of virtual patient communities where patients and health care consumers can share their health experiences and seek information from one another. These platforms are potentially rich sources of patient-generated health data, which could be used in some cases as real-world evidence to help protect public health and promote health care innovation. The Committee will discuss whether and how the FDA can harness patient-driven online and mobile platforms to better engage with patients and consumers, as well as to collect and evaluate real-world data in the form of health information provided by patients and consumers.

Date: Thursday, November 15

Time: 8:00 am – 5:00 pm ET

Location: Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD

Social Media: Use #PEAC2018 to stay connected

To submit written comments: Email Letise Williams at Letise.Williams@fda.hhs.gov by Oct. 23rd

The Patient Engagement Advisory Committee is the first FDA advisory committee focused wholly on patients and patient-related issues. Members, including patient representatives, a consumer representative, and a non-voting industry representative (selected based on the topic), provide advice to the Commissioner of the FDA on complex issues relating to medical devices, the regulation of devices, and their use by patients.

Learn More:

Should you wish to opt-out of future communications from the Patient Affairs Staff, please send an email to PatientAffairs@fda.hhs.gov.

Patient Affairs Staff (PAS)
Office of Medical Products and Tobacco
U.S. Food and Drug Administration

Tel: 301-796-8460
Email: PatientAffairs@fda.gov